AMAT
60
7
AMT
26
-12
GOOGL
51
12
LB
55
11
COST
54
3
ED
45
-4
MOS
72
10
HES
47
4
IFF
48
6
BBY
58
6
CPB
47
5
CME
59
-12
LRCX
74
10
MCO
78
4
AKAM
40
5
OI
55
3
GT
50
4
INTC
35
6
AME
66
6
DTE
54
-4
AMAT
60
7
AMT
26
-12
GOOGL
51
12
LB
55
11
COST
54
3
ED
45
-4
MOS
72
10
HES
47
4
IFF
48
6
BBY
58
6
CPB
47
5
CME
59
-12
LRCX
74
10
MCO
78
4
AKAM
40
5
OI
55
3
GT
50
4
INTC
35
6
AME
66
6
DTE
54
-4
Financhill
Back

Verona Pharma PLC 10K Form

Buy
64

VRNA
Verona Pharma PLC

Last Price:
$67.49
Seasonality Move:
16.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q VRNA/Verona Pharma PLC Quarterly
2023-08-03 10Q VRNA/Verona Pharma PLC Quarterly
2023-05-09 10Q VRNA/Verona Pharma PLC Quarterly
2022-11-09 10Q VRNA/Verona Pharma PLC Quarterly
2022-08-09 10Q VRNA/Verona Pharma PLC Quarterly
2022-05-03 10Q VRNA/Verona Pharma PLC Quarterly

Receive VRNA News And Ratings

See the #1 stock for the next 7 days that we like better than VRNA

VRNA Financial Statistics

Sales & Book Value

Annual Sales: $42.3M
Cash Flow: $-12.1M
Price / Cash Flow: 0
Annual Sales: $2.66
Price / Book: 25.37

Profitability

EPS (TTM): -2.00000
Net Income (TTM): $-163.9M
Gross Margin: $39.7M
Return on Equity: -85.84%
Return on Assets: -38.92%

Verona Pharma PLC Earnings Forecast

Key Verona Pharma PLC Financial Ratios

  • The Gross Profit Margin over the past 14 years for VRNA is 93.89%.
  • The Selling, General & Administrative Expenses for VRNA have been equal to 354.19% of Gross Profit Margin.
  • The Research & Development expenses have been 105.43% of Revenue.
  • The Net Earning history of VRNA is -410.18% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 9 years.

Verona Pharma PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: VRNA
CUSIP: 925050
Website: veronapharma.com

Debt

Debt-to-Equity Ratio: 1.07
Current Ratio: 8.86
Quick Ratio: 8.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 213.74

VRNA Technical Analysis vs Fundamental Analysis

Buy
64
Verona Pharma PLC (VRNA) is a Buy

Is Verona Pharma PLC a Buy or a Sell?

  • Verona Pharma PLC stock is rated a Buy
    The current Verona Pharma PLC [VRNA] share price is $67.53. The Score for VRNA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.